News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
828,699 Results
Type
Article (85433)
Company Profile (695)
Press Release (742571)
Section
Business (231895)
Career Advice (4106)
Deals (39642)
Drug Delivery (115)
Drug Development (90547)
Employer Resources (194)
FDA (17910)
Job Trends (17269)
News (394936)
Policy (39584)
Tag
Academia (2972)
Alliances (56389)
Alzheimer's disease (1318)
Approvals (17846)
Artificial intelligence (133)
Bankruptcy (394)
Best Places to Work (12436)
Biotechnology (480)
Breast cancer (111)
Cancer (1046)
Career advice (3512)
Cell therapy (258)
Clinical research (71289)
Collaboration (370)
Compensation (167)
COVID-19 (2785)
C-suite (91)
Data (1001)
Diabetes (113)
Diagnostics (6603)
Earnings (94115)
Employer resources (166)
Events (126186)
Executive appointments (267)
FDA (18341)
Funding (314)
Gene therapy (195)
GLP-1 (635)
Government (5021)
Healthcare (20637)
Infectious disease (2853)
Inflammatory bowel disease (120)
Interviews (807)
IPO (17542)
Job creations (5178)
Job search strategy (2855)
Layoffs (482)
Legal (10015)
Lung cancer (165)
Manufacturing (181)
Medical device (14274)
Medtech (14279)
Mergers & acquisitions (22032)
Metabolic disorders (375)
Neuroscience (1581)
NextGen Class of 2024 (7644)
Non-profit (5050)
Northern California (1323)
Obesity (209)
Opinion (244)
Patents (98)
People (64021)
Pharmaceutical (137)
Phase I (21966)
Phase II (30984)
Phase III (23333)
Pipeline (419)
Podcasts (90)
Postmarket research (3533)
Preclinical (9942)
Radiopharmaceuticals (245)
Rare diseases (214)
Real estate (7369)
Regulatory (25825)
Research institute (2638)
Resumes & cover letters (648)
Southern California (1171)
Startups (4273)
United States (12547)
Vaccines (615)
Weight loss (175)
Date
Today (72)
Last 7 days (570)
Last 30 days (3173)
Last 365 days (35514)
2024 (32367)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (213)
Asia (49216)
Australia (8681)
California (3037)
Canada (1100)
China (234)
Colorado (135)
Connecticut (123)
Europe (112670)
Florida (359)
Georgia (89)
Illinois (335)
Indiana (183)
Kansas (103)
Maryland (578)
Massachusetts (2548)
Michigan (146)
Minnesota (249)
New Jersey (886)
New York (870)
North Carolina (785)
Northern California (1323)
Ohio (121)
Pennsylvania (726)
South America (1646)
Southern California (1171)
Texas (411)
Washington State (359)
828,699 Results for "bio tissue".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Q32 Bio Announces Publication of Preclinical Data in Molecular Therapy Demonstrating the Therapeutic Potential of Tissue-Targeted Complement Inhibitor ADX-097 for Complement-Mediated Diseases
Q32 Bio Inc., a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, today announced the publication of preclinical data in Molecular Therapy that further validates the therapeutic potential of ADX-097, a tissue-targeted complement inhibitor.
February 21, 2024
·
11 min read
Press Releases
Adela to Present Biological Insights into its Tissue-Agnostic Assay for Molecular Residual Disease Detection at the AACR Special Conference in Cancer Research
November 15, 2024
·
3 min read
Press Releases
Brinter AM Technologies will provide a 3D bioprinter for Advanced Tissue Manufacturing capabilities at the International Space Station (ISS) for an ESA project.
With a commitment to foster space exploration and terrestrial benefits through human spaceflight activities, ESA is investigating microgravity’s effects on human tissue to develop solutions that keep astronauts healthy during long-term missions and improve Life on Earth.
August 29, 2024
·
3 min read
Layoffs
Bluebird Bio to Lay Off 25% of Workforce
About a month after reporting it’s had a tough time starting enough patients on its treatments, bluebird bio announced it will lay off about 25% of its employees, over half of whom work in R&D.
September 24, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector
October 1, 2024
·
2 min read
Business
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer.
May 20, 2024
·
5 min read
Press Releases
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
November 6, 2024
·
5 min read
Business
TELA Bio Reports First Quarter 2024 Financial Results
TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions reported financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
8 min read
Press Releases
ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
September 19, 2024
·
6 min read
Layoffs
IN8bio to Lay Off About 49% of Employees
Facing financial challenges, IN8bio is looking to preserve cash resources through a pipeline prioritization and layoffs at its New York City and Birmingham, Alabama, sites.
September 5, 2024
·
1 min read
·
Angela Gabriel
1 of 82,870
Next
